Organovo Releases Latest Fiscal Report

Organovo has just released their fiscal Q3 report for 2017, showing a net loss of $9.6 million, or $0.09 per share—down from $10.5 million, or $0.11 per share, for the fiscal third quarter of 2016. Revenues however, are up by an astounding 139 percent in comparison to last year. This increase is due largely to new tissue contracts for Organovo. Operating expenses were down 11 percent and the company showed working capital of $67.5 million, in comparison to $65.2 million for this quarter last year. For 2017 in total, they project revenues between $3.7 million and $4.5 million, in comparison to 2016 at $1.5 million. Read more at 3DPrint.com: https://3dprint.com/164853/organovo-...eport-q3-2017/

https://3dprint.com/wp-content/uploa.../02/kidney.png